Pleiotropic and epistatic effects in sickle cell anemia

Current Opinion in Hematology

Volumn 8, Issue 2, 2001, Pages 105-110

  Nagel, Ronald L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE SEVERITY; EPISTASIS; GENE MUTATION; GLOBIN GENE; HUMAN; HUMAN CELL; MONOGENIC DISORDER; PATHOPHYSIOLOGY; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; ANIMALS; EPISTASIS, GENETIC; HUMANS; PHENOTYPE;

EID: 0035097063     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200103000-00008     Document Type: Article

References (75)

1. Hemoglobin S gelation and sickle cell disease
2. Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic properties
3. Deformability of oxygenated irreversibly sickled cells
4. Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle cell anemia
5. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity
6. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications
7. Volume-dependent and NEM-stimulated K/Cl cotransport is elevated in SS, SC and CC human red cells
8. Regulation of erythrocyte cation and water content in sickle cell anemia
9. Maximum urine concentrating ability in children with Hb SC disease: Effects of hydroxyurea
10. Genetic variability in sickle cell anemia
11. Genetic influences on F cells and other hematological variables: A twin heritability study
12. Increased HbF in sickle cel anemia is determined by a factor linked to the α S gene from one parent
13. Bias WB production of F cells in sickle cell anemia: Regulation by a genetic locus or loci separate form the β-globin gene cluster
14. MSH patient's follow-up concordant HbF response to hydroxyurea (HU) in siblings with sickle cell anemia (HbSS)
15. Concurrent sickle cell anemia and α-thalassemia: Effect on pathological properties of sickle erythrocytes
16. Genetic epidemiology of the βS gene
17. X-linked dominant control of F-cells in normal adult life: Characterization of the Swiss type as hereditary persistence of fetal hemoglobin regulated dominantly by gene(s) on X chromosome
18. αβFetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X- linked: Many issues and some answers
19. Sickle cell anemia is a multigene disease: Sickle painful crises, a case in point
20. General pathophysiology of sickle cell anemia
21. Monoclonal antibodies to αVβ 3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet- activating factor
22. Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow
23. Sickle erythrocyte-endothelial interactions in microcirculation: The role of von Willebrand factor and implications for vasoocclusion
24. Thrombospondin mediates CD36+ sickle reticulocytes to endothelial cells
25. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vaso-occlusion
26. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: A potential role for platelet activation in sickle cell vaso-occlusion
27. Sickle reticulocytes adhere to VCAM-1
28. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor
29. Requirement of vascular integrin alpha v beta 3 for angiogenesis
30. Cell attachment to thrombospondin: The role of ARG-GLY- ASP calcium and integrin receptors
31. Anionic polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior
32. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
33. In vivo demonstration of red cell-endothelial interactions, sickling and altered microvascular response to oxygen in the sickle transgenic mouse
34. Interstitial diffusion of macromolecules in the rat mesentery
35. Inhibition of histamine-induced protein leakage in rat skeletal muscle blockade of prostaglandin synthesis
36. Renal nitric oxide synthases in transgenic sickle cell mice
37. Elevated immunoreactive necrosis factor and interleukin-1 in sickle cell anemia
38. Impaired nitric oxide-mediated vasodilation in transgenic mice
39. Volume-dependent and NEM-stimulated K/Cl cotransport is elevated in SS, SC and CC human red cells
40. Red blood cells of a transgenic mouse expressing high levels of human hemoglobin S exhibit deoxy-stimulated cation flux
41. Cl cotransport in red cells of a transgenic mouse expressing high levels of human hemoglobin S
42. Inhibition of Ca++-dependent K transport and cell dehydration in sickle erythrocytes by clotrimazol and other imidazole derivatives
43. Treatment with oral clotrimazol blocks Ca++-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice
44. cDNA cloning and functional characterization of the mouse Ca2+-gated K+ channel, mlK1. Roles in regulatory volume decrease and erythroid differentiation
45. Molecular identification and expression of erythroid K:C1 cotransporter in human and mouse erythroleukemic cells
46. Expression of Na+/H+ exchanger isoforms NHE1 and NHE3 in kidney and blood cells of rabbit and rat
47. Na+/H+ exchange is increased n sickle cell anemia and young normal red cells
48. Stroke in sickle cell disease: Demographic, clinical and therapeutic considerations
49. Transfusion therapy for cerebrovascular abnormalities in sickle cell disease
50. Sickle cell anemia and central nervous system infarction A neuropathological study
51. Neurologic complications of sickle cell disease
52. Mechanisms of stroke in sickle cell disease: Sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition
53. Endothelial dysfunction, hemodynamic forces and atherosclerosis
54. Dual perspective analysis of vascular formations in sickle cell retinopathy
55. Adhesion molecules, neutrophils and imbalance in the fibrinolytic system in sickle cell retinopathy
56. Immunohistochemical insights into sickle cell retinopathy
57. Histopathological features of neovasoularization in sickle cell retinopathy
58. Ophthalmologic complications
59. Olphalmological complications in sickle cell anemia
60. Angiogenic factors in human proliferative sickle cell retinopathy
61. Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease
62. Nonperfusion of retina and choroid in transgenic mouse models of sickle cell disease
63. A rat model for sickle cell-mediated vaso-occlusion in retina
64. Circulating BFU-E in sickle cell anemia: Relationship to % HbF and BPA-like activity
65. Heterogeneity in the properties of burst-forming units of erythroid lineage in sickle cell anemia: DNA synthesis and burst-promoting activity production is related to peripheral hemoglobin F levels
66. Circulating cytokines in SS patients during steady state
67. Circulating cytokines response and the level of erythropoiesis in sickle cell anemia
68. Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized
69. Autoxidation, dehydration, and adhesivity may be related abnormalities of sickle erythrocytes
70. Membrane-associated iron
71. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women
72. Will the genetic individualization of disease force a new paradigm?